“ABNORMAL RETINAL REFLECTIVITY TO SHORT-WAVELENGTH LIGHT IN TYPE 2 IDIOPATHIC MACULAR TELANGIECTASIA.”, Retina, vol. 38 Suppl 1, pp. S79-S88, 2018.
, “Adherence to a Mediterranean diet and cognitive function in the Age-Related Eye Disease Studies 1 & 2.”, Alzheimers Dement, vol. 16, no. 6, pp. 831-842, 2020.
, “Adherence to the Mediterranean Diet and Progression to Late Age-Related Macular Degeneration in the Age-Related Eye Disease Studies 1 and 2.”, Ophthalmology, 2020.
, “The Age-Related Eye Disease Study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1).”, Ophthalmology, vol. 119, no. 11, pp. 2282-9, 2012.
, “Association of 2-Year Progression Along the AREDS AMD Scale and Development of Late Age-Related Macular Degeneration or Loss of Visual Acuity: AREDS Report 22.”, JAMA Ophthalmol, 2020.
, “The Association of Aspirin Use with Age-Related Macular Degeneration Progression in the Age-Related Eye Disease Studies: Age-Related Eye Disease Study 2 Report No. 20.”, Ophthalmology, vol. 126, no. 12, pp. 1647-1656, 2019.
, “Association of Dietary and Supplementary Calcium Intake With Age-Related Macular Degeneration: Age-Related Eye Disease Study Report 39.”, JAMA Ophthalmol, vol. 137, no. 5, pp. 543-550, 2019.
, “The Association of Dietary Lutein plus Zeaxanthin and B Vitamins with Cataracts in the Age-Related Eye Disease Study: AREDS Report No. 37.”, Ophthalmology, vol. 122, no. 7, pp. 1471-9, 2015.
, “Association of Mortality with Ocular Diseases and Visual Impairment in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report Number 13.”, Ophthalmology, vol. 125, no. 4, pp. 512-521, 2018.
, “The Association of Statin Use with Age-Related Macular Degeneration Progression: The Age-Related Eye Disease Study 2 Report Number 9.”, Ophthalmology, vol. 122, no. 12, pp. 2490-6, 2015.
, “The Association of Statin Use with Cataract Progression and Cataract Surgery: The AREDS2 Report Number 8.”, Ophthalmology, vol. 123, no. 4, pp. 916-7, 2016.
, “Associations of mortality and diabetes complications in patients with type 1 and type 2 diabetes: early treatment diabetic retinopathy study report no. 27.”, Diabetes Care, vol. 28, no. 3, pp. 617-25, 2005.
, “Baseline characteristics of participants in the natural history study of macular telangiectasia (MacTel) MacTel Project Report No. 2.”, Ophthalmic Epidemiol, vol. 17, no. 1, pp. 66-73, 2010.
, “Bivariate Analysis of Age-Related Macular Degeneration Progression Using Genetic Risk Scores.”, Genetics, vol. 206, no. 1, pp. 119-133, 2017.
, “Cardiovascular risk of celecoxib in 6 randomized placebo-controlled trials: the cross trial safety analysis.”, Circulation, vol. 117, no. 16, pp. 2104-13, 2008.
, “Changes in lens opacities on the age-related eye disease study grading scale predict progression to cataract surgery and vision loss: age-related eye disease study report no. 34.”, Ophthalmology, vol. 122, no. 5, pp. 888-96, 2015.
, “CHARACTERISTICS OF PIGMENTED LESIONS IN TYPE 2 IDIOPATHIC MACULAR TELANGIECTASIA.”, Retina, vol. 38 Suppl 1, pp. S43-S50, 2018.
, “Ciliary neurotrophic factor for macular telangiectasia type 2: results from a phase 1 safety trial.”, Am J Ophthalmol, vol. 159, no. 4, pp. 659-666.e1, 2015.
, “Complement factor H polymorphism in age-related macular degeneration.”, Science, vol. 308, no. 5720, pp. 385-9, 2005.
, “CORRELATION OF CLINICAL AND STRUCTURAL PROGRESSION WITH VISUAL ACUITY LOSS IN MACULAR TELANGIECTASIA TYPE 2: MacTel Project Report No. 6-The MacTel Research Group.”, Retina, vol. 38 Suppl 1, pp. S8-S13, 2018.
, “CORRELATION OF STRUCTURAL AND FUNCTIONAL OUTCOME MEASURES IN A PHASE ONE TRIAL OF CILIARY NEUROTROPHIC FACTOR IN TYPE 2 IDIOPATHIC MACULAR TELANGIECTASIA.”, Retina, vol. 38 Suppl 1, pp. S27-S32, 2018.
, “A Crossover Design for Comparative Efficacy: A 36-Week Randomized Trial of Bevacizumab and Ranibizumab for Diabetic Macular Edema.”, Ophthalmology, vol. 123, no. 4, pp. 841-9, 2016.
, “A Deep Phenotype Association Study Reveals Specific Phenotype Associations with Genetic Variants in Age-related Macular Degeneration: Age-Related Eye Disease Study 2 (AREDS2) Report No. 14.”, Ophthalmology, vol. 125, no. 4, pp. 559-568, 2018.
, “Dietary Nutrient Intake and Progression to Late Age-Related Macular Degeneration in the Age-Related Eye Disease Studies 1 and 2”, Ophthalmology, vol. 128, no. 3, pp. 425-442, 2021.
, “Dose-ranging study of lutein supplementation in persons aged 60 years or older.”, Invest Ophthalmol Vis Sci, vol. 47, no. 12, pp. 5227-33, 2006.
,